A
ABP (Activation By Personalization)
A LoRaWAN device activation method in which the session keys (NwkSKey and AppSKey) and device address (DevAddr) are pre-programmed into the device before deployment, without requiring an over-the-air join procedure. ABP eliminates the join latency but requires careful key management and is generally not recommended for GxP deployments due to the absence of a join audit trail. See also: OTAA.
ADR (Adaptive Data Rate)
A LoRaWAN network mechanism by which the network server dynamically adjusts a device's spreading factor, bandwidth, and transmit power based on observed link quality. ADR optimizes the trade-off between range, data rate, and battery life. In GxP environments, changes to ADR-controlled parameters must be evaluated as potential configuration changes if they affect validated performance. See also: Spreading Factor, Bandwidth.
ALCOA+
A data integrity framework defining the attributes that pharmaceutical records must possess: Attributable, Legible, Contemporaneous, Original, Accurate, and the "+" attributes: Complete, Consistent, Enduring, and Available. ALCOA+ is the foundational data quality standard applied to all GxP electronic records, including LoRaWAN sensor data stored in the application platform. Referenced by FDA, WHO, MHRA, and PIC/S data integrity guidances.
Annual Product Quality Review (APQR)
A periodic review, typically conducted annually, of the quality performance of a medicinal product. APQR includes review of environmental monitoring data trends, deviations, CAPAs, and system changes. LoRaWAN monitoring system KPI data feeds into the APQR as evidence of continued system performance. See also: KPI.
ANVISA (Agência Nacional de Vigilância Sanitária)
Brazil's national health surveillance agency, responsible for the sanitary regulation of foods, drugs, medical devices, cosmetics, and other health-related products in Brazil. ANVISA's GxP regulatory framework — issued as RDC (Resoluções da Diretoria Colegiada) resolutions and IN (Instrução Normativa) normative instructions — is harmonized with FDA and EU GMP standards, including requirements for electronic records, data integrity, and computerized system validation. For LoRaWAN environmental monitoring systems deployed in Brazilian pharmaceutical facilities, ANVISA compliance is the primary regulatory driver alongside FDA and EMA requirements. See also: GMP, GxP, FDA, EMA.
API (Active Pharmaceutical Ingredient)
The biologically active component of a pharmaceutical product responsible for its therapeutic effect. APIs often have defined storage temperature and humidity limits, making their storage areas subject to GxP environmental monitoring. Not to be confused with Application Programming Interface (also abbreviated API) in the software context.
Application Platform
The software layer of the LoRaWAN system responsible for receiving decoded sensor data from the network server, applying business logic (alarm thresholds, escalation rules, reporting), storing records, and providing the user interface. In GxP environments, the application platform is the primary subject of electronic records and electronic signatures requirements (FDA 21 CFR Part 11, EU Annex 11). Typically classified as GAMP Category 4 (configured commercial software) or Category 5 (custom-developed). See also: Network Server, GAMP 5.
AppEUI* (also JoinEUI in LoRaWAN 1.1)*
A 64-bit global application identifier used in OTAA join procedures to identify the application server to which a device belongs. Together with the DevEUI, the AppEUI uniquely identifies a device's application context within the LoRaWAN network. See also: DevEUI, OTAA.
AppKey
A 128-bit AES cryptographic root key pre-provisioned in a LoRaWAN device and in the join server, used during the OTAA join procedure to derive session keys. The AppKey must be securely managed; its compromise allows an attacker to impersonate devices or decrypt application payloads. See also: OTAA, AppSKey, NwkSKey.
AppSKey (Application Session Key)
A 128-bit AES session key derived during the OTAA join procedure, used to encrypt and decrypt the application payload of LoRaWAN messages. The AppSKey is known only to the device and the application server, ensuring end-to-end payload confidentiality. See also: NwkSKey, OTAA.
Audit Trail
A secure, computer-generated, time-stamped electronic record that allows reconstruction of the course of events relating to the creation, modification, or deletion of an electronic record. In LoRaWAN systems, audit trail requirements apply primarily to the application platform: user access events, alarm acknowledgements, configuration changes, and data corrections must all be captured in a tamper-evident audit trail. Required by FDA 21 CFR Part 11, EU Annex 11, and ALCOA+ principles. See also: Electronic Record, ALCOA+.
B
Bandwidth (BW)
In LoRaWAN, the radio frequency bandwidth of a LoRa transmission, typically 125 kHz, 250 kHz, or 500 kHz. Wider bandwidth increases data rate but reduces receiver sensitivity. In the EU868 band, 125 kHz is standard for uplink transmissions. See also: ADR, Spreading Factor.
BLE (Bluetooth Low Energy)
A short-range wireless protocol (range typically 10–30 m) used in some hybrid LoRaWAN architectures, where BLE-enabled sensors transmit to a BLE-LoRaWAN bridge that forwards data over LoRaWAN. BLE is also used for local sensor configuration and diagnostics.
C
CAPA (Corrective and Preventive Action)
A structured quality management process for investigating the root cause of a deviation or non-conformance (corrective action) and implementing changes to prevent recurrence (preventive action). In LoRaWAN monitoring systems, CAPAs may arise from repeated alarm threshold breaches, sensor failures, calibration failures, or data integrity findings. See also: Deviation.
Change Control
A formal quality system process for evaluating, approving, implementing, and documenting changes to validated systems, equipment, or processes. Any change to a validated LoRaWAN system — including firmware updates, configuration changes, sensor replacements, gateway additions, or network server upgrades — must pass through change control before implementation. See also: Validation.
Class A (LoRaWAN Device Class)
The baseline LoRaWAN device class, implemented by all LoRaWAN devices. Class A devices transmit an uplink and then open two short receive windows for potential downlinks. Between transmissions, the device sleeps, maximizing battery life. Class A is the most common class for battery-powered environmental sensors. See also: Class B, Class C.
Class B (LoRaWAN Device Class)
A LoRaWAN device class that supplements Class A receive windows with scheduled beacon-synchronized receive windows, enabling the network server to send downlinks at predictable times. Class B is used where controllable downlink latency is required — for example, actuators or sensors requiring frequent configuration updates. See also: Class A, Class C.
Class C (LoRaWAN Device Class)
A LoRaWAN device class in which the device keeps its receiver open continuously except during uplink transmissions, enabling near-instantaneous downlink delivery. Class C devices consume significantly more power (typically requiring mains power) but allow real-time control commands. See also: Class A, Class B.
cGMP (current Good Manufacturing Practice)
The current edition of Good Manufacturing Practice regulations, with the "c" prefix emphasizing that requirements are continuously updated to reflect the latest advances in pharmaceutical manufacturing and quality science. Used primarily in the United States context (FDA 21 CFR Parts 210/211) to indicate active enforcement and ongoing regulatory evolution. The EU equivalent is simply "EU GMP." In practice, GMP and cGMP are used interchangeably in international pharmaceutical documentation. See also: GMP, GxP, FDA.
Coding Rate (CR)
A LoRa modulation parameter defining the ratio of data bits to total bits transmitted, providing forward error correction. A higher coding rate (e.g., 4/8) provides more error correction but reduces effective data rate. Coding rate is typically fixed at 4/5 in most LoRaWAN deployments.
CQA (Critical Quality Attribute)
A physical, chemical, biological, or microbiological property or characteristic of a drug substance or product that must be within an appropriate limit, range, or distribution to ensure the desired product quality. In the context of environmental monitoring, CQAs define what the LoRaWAN system must protect: temperature-sensitive product integrity, sterile manufacturing environment control, humidity-sensitive material stability, and stability study conditions. Defined by ICH Q8. See also: Critical Zone, ICH Q9.
Critical Zone
A monitored physical area in which a monitoring failure — a missed excursion, a data gap, or a sensor outage — could directly affect a Critical Quality Attribute and, by extension, product quality or patient safety. Monitoring data from critical zones directly supports product release decisions or regulatory classifications. A data gap in a critical zone requires a formal deviation investigation and may result in product rejection. Typical critical zones include temperature-controlled finished product storage, API storage, stability chambers, and cleanroom environments. See also: Standard Zone, CQA, PDR.
D
Data Integrity
The degree to which data is complete, consistent, accurate, trustworthy, and reliable throughout the data lifecycle (from creation through archiving or disposal). In pharmaceutical GxP environments, data integrity is governed by ALCOA+ principles and enforced through technical controls (audit trails, access controls, electronic signatures) and procedural controls (SOPs, training). See also: ALCOA+, Audit Trail.
DevAddr (Device Address)
A 32-bit address assigned to a LoRaWAN device within a network, used for routing messages within the LoRaWAN network. In OTAA, the DevAddr is assigned by the network server during the join procedure. In ABP, it is pre-configured. Unlike the DevEUI, the DevAddr is not globally unique and may be reused across different networks. See also: DevEUI, OTAA, ABP.
DevEUI (Device EUI)
A 64-bit globally unique identifier assigned to a LoRaWAN device by the manufacturer, analogous to a MAC address. The DevEUI identifies the specific physical device and is used in the OTAA join procedure. In GxP deployments, the DevEUI is the primary device identifier recorded in the IQ documentation and the device registry. See also: OTAA, IQ.
Deviation
A departure from an approved standard, procedure, or specification. In the context of LoRaWAN monitoring, a deviation may be triggered by an environmental excursion (temperature or humidity outside limits), a system failure (sensor outage, data gap), or a process non-conformance (missed alarm acknowledgement). Deviations require formal investigation and documentation. See also: CAPA.
Downlink
A LoRaWAN message transmitted from the network infrastructure (network server → gateway → device). Downlinks are used for device configuration, firmware updates, acknowledgements, and commands. The timing and frequency of downlinks are constrained by gateway duty cycle regulations. See also: Uplink, Class A, Class B, Class C.
Duty Cycle
The proportion of time that a radio transmitter is active. In the EU868 frequency band, LoRaWAN devices and gateways are subject to a maximum duty cycle of 1% per sub-band, imposed by regulatory authority (ETSI). Duty cycle limits restrict how frequently a gateway can transmit downlinks and must be considered in system design, particularly for systems requiring frequent confirmed uplinks or remote configuration.
E
Electronic Record
Any combination of text, graphics, data, audio, pictorial, or other information representation in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system. Under FDA 21 CFR Part 11 and EU Annex 11, electronic records used in lieu of paper records must meet specific requirements for system access controls, audit trails, and data integrity. LoRaWAN sensor data stored in the application platform constitutes an electronic record. See also: Electronic Signature, Audit Trail.
Electronic Signature
A computer data compilation of any symbol or series of symbols executed, adopted, or authorized by an individual to be the legally binding equivalent of the individual's handwritten signature. Under FDA 21 CFR Part 11, electronic signatures on GxP records must be linked to their respective records and must include the signer's name, date and time, and the meaning of the signature. See also: Electronic Record.
EMA (European Medicines Agency)
The European Union agency responsible for the scientific evaluation, supervision, and safety monitoring of medicines across EU member states. EMA oversees the EU GMP framework — including Annex 11 (computerized systems), Annex 15 (qualification and validation), and the EU GDP Guidelines — that governs pharmaceutical manufacturing and distribution in the EU. EMA inspections and EU GMP compliance are a primary driver for computerized system validation, including LoRaWAN monitoring systems, at facilities operating in or exporting to EU markets. See also: EU Annex 11, GMP, GxP.
EU Annex 11
European Union GMP guideline governing computerized systems used in pharmaceutical manufacturing and quality control. Annex 11 addresses validation, data integrity, electronic records, audit trails, backup and recovery, and business continuity. Together with FDA 21 CFR Part 11, it is the primary regulatory reference for application platform validation in LoRaWAN GxP deployments.
F
FDA (Food and Drug Administration)
The United States federal agency responsible for protecting public health by overseeing the safety, efficacy, and security of foods, drugs, biologics, medical devices, and cosmetics. In the context of GxP pharmaceutical environments, the FDA issues and enforces regulations including 21 CFR Part 11 (electronic records and signatures), 21 CFR Parts 210/211 (GMP for finished pharmaceuticals), and guidance documents on data integrity, computer software assurance (CSA), and process validation. FDA inspections are among the most rigorous in the pharmaceutical industry and are the primary driver of GxP computerized system validation requirements for facilities serving the US market. See also: FDA 21 CFR Part 11, cGMP, GxP.
FDA 21 CFR Part 11
United States Code of Federal Regulations, Title 21, Part 11: Electronic Records; Electronic Signatures. Establishes requirements for the use of electronic records and electronic signatures in FDA-regulated activities. The foundational regulatory reference for application platform audit trail, access control, and electronic signature requirements in LoRaWAN GxP systems. See also: EU Annex 11, Electronic Record.
FMEA (Failure Mode and Effects Analysis)
A structured risk analysis methodology that systematically identifies failure modes — the ways in which a system component can fail — and evaluates the severity, probability, and detectability of each failure's consequences, expressed as a Risk Priority Number (RPN = S × P × D). In LoRaWAN validation, FMEA is used to identify and mitigate failure modes specific to wireless, distributed, battery-powered architecture. See also: ICH Q9, Risk Assessment.
FUOTA (Firmware Update Over The Air)
A LoRaWAN Alliance-standardized mechanism for delivering firmware updates to LoRaWAN devices without physical access, using multicast downlinks and fragmented data transfer. In GxP environments, FUOTA-delivered firmware updates must be managed through change control and documented as a configuration change to the validated system. See also: Change Control.
G
GAMP 5 (Good Automated Manufacturing Practice, 5th edition)
A guidance document published by ISPE (International Society for Pharmaceutical Engineering) providing a risk-based framework for the validation of computerized systems in the pharmaceutical industry. GAMP 5 classifies software into categories (1: infrastructure, 3: non-configured, 4: configured, 5: custom) and prescribes validation depth proportional to category and risk. The 2nd edition (2022) emphasizes computer software assurance (CSA) and risk-based approaches. See also: IQ, OQ, PQ, Risk Assessment.
Gateway
A LoRaWAN network component that receives RF transmissions from devices using LoRa modulation and forwards them to the network server over a backhaul connection (Ethernet, cellular, or Wi-Fi). Gateways are transparent to LoRaWAN encryption and do not decode application payloads. In GxP environments, gateways must be qualified through IQ and their placement documented to demonstrate RF coverage of all monitored zones. See also: Network Server, IQ.
GDP (Good Distribution Practice)
Regulatory guidelines governing the proper distribution of medicinal products for human use. GDP includes requirements for temperature-controlled storage and transport, with specific temperature monitoring obligations for cold chain products. The EU GDP Guidelines (2013/C 343/01) and WHO Technical Report Series 957 are the primary references for cold chain LoRaWAN deployments. See also: Cold Chain.
GMP (Good Manufacturing Practice)* (also cGMP — current Good Manufacturing Practice)*
Regulatory requirements governing the manufacturing, testing, and quality assurance of pharmaceutical products to ensure they meet defined quality standards. GMP regulations include requirements for environmental monitoring of manufacturing and storage areas. See also: GxP.
GxP
A collective term for all pharmaceutical "Good Practice" guidelines: GMP (Manufacturing), GDP (Distribution), GLP (Laboratory), GCP (Clinical), and GPvP (Pharmacovigilance). In this book, GxP is used to refer collectively to the regulatory quality framework that governs pharmaceutical operations and the systems supporting them.
I
ICH Q9
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, Guideline Q9: Quality Risk Management. Provides principles and tools for risk management in pharmaceutical quality systems, including risk assessment, risk control, and risk communication. The foundational framework for LoRaWAN system risk assessment, FMEA, and validation scope determination. See also: FMEA, Risk Assessment.
IQ (Installation Qualification)
The documented verification that a system or equipment has been installed in accordance with its approved specifications. For LoRaWAN systems, IQ covers physical installation verification (sensors, gateways), configuration verification (device parameters, network server settings, application platform configuration), and documentation completeness (calibration certificates, supplier documentation). IQ is a prerequisite for OQ. See also: OQ, PQ, Validation.
IoT (Internet of Things)
A network of physical devices embedded with sensors, software, and connectivity that enables them to collect and exchange data. LoRaWAN is an LPWAN protocol specifically designed for IoT applications requiring long range and low power consumption.
ISPE (International Society for Pharmaceutical Engineering)
A global not-for-profit professional association serving pharmaceutical engineering and manufacturing professionals. ISPE is best known in the GxP validation context as the publisher of GAMP 5 (Good Automated Manufacturing Practice, 5th edition), the industry's primary guidance for risk-based computerized system validation. ISPE also publishes Good Practice Guides on data integrity, temperature-controlled distribution, pharmaceutical facilities, and process equipment. See also: GAMP 5.
K
KPI (Key Performance Indicator)
A quantifiable measurement used to evaluate system performance against defined targets. In LoRaWAN GxP monitoring, KPIs include Packet Delivery Rate, gateway availability, silence alarm response compliance, and signal quality trends. KPIs are monitored on a defined periodic basis (typically monthly) and reported in periodic review meetings and APQR documentation. See also: PDR, APQR.
L
LoRa
A proprietary chirp spread spectrum (CSS) modulation technique developed by Semtech, used as the physical layer for LoRaWAN. LoRa provides long-range, low-power wireless communication and is the basis for LoRaWAN's ability to penetrate building materials and cover large areas. LoRa is the modulation; LoRaWAN is the protocol built on top of it.
LoRaWAN
A wide-area networking protocol and system architecture defined by the LoRa Alliance, built on the LoRa physical layer. LoRaWAN defines the communication protocol, network architecture, security (AES-128 encryption, device authentication), device classes (A/B/C), and adaptive data rate mechanisms. LoRaWAN is the primary technology addressed in this book. See also: LoRa, Network Server, Gateway.
LPWAN (Low-Power Wide-Area Network)
A category of wireless network technologies designed for long-range communication with low power consumption and low data rates, suitable for IoT devices operating on battery power for years. LoRaWAN is the leading LPWAN standard in pharmaceutical applications. Other LPWAN technologies include Sigfox and NB-IoT.
M
MHRA (Medicines and Healthcare products Regulatory Agency)
The United Kingdom's regulatory agency responsible for ensuring that medicines, medical devices, and blood components meet applicable standards of safety, quality, and efficacy. The MHRA has been particularly influential in the global pharmaceutical data integrity landscape: its 2015 and 2018 guidance documents introduced stringent expectations for audit trail review, data governance, and computerized system controls that have since been reflected in FDA, EMA, and PIC/S guidance documents. For LoRaWAN monitoring systems at UK or UK-exporting facilities, MHRA compliance requirements closely mirror those of EU Annex 11. See also: Data Integrity, Audit Trail, ALCOA+, PIC/S.
MKT (Mean Kinetic Temperature)
A single calculated temperature that expresses the cumulative thermal stress experienced by a product during storage or transport, taking into account the Arrhenius equation for reaction rate temperature dependence. MKT is used in cold chain and stability assessments to determine whether a temperature excursion has caused product degradation. Defined in USP <1196> and ICH Q1A.
MQTT (Message Queuing Telemetry Transport)
A lightweight publish-subscribe messaging protocol commonly used for integrating LoRaWAN network servers with application platforms and external systems. LoRaWAN network servers typically expose decoded device data via MQTT topics, which application platforms or integration middleware subscribe to.
N
Network Server
The central software component of a LoRaWAN network responsible for managing device sessions, deduplicating uplinks received by multiple gateways, handling MAC layer communications, applying ADR, routing messages to application servers, and managing downlink scheduling. The network server does not decrypt application payloads. In GxP environments, the network server must be qualified as part of the system validation scope. See also: Application Platform, Gateway, ADR.
O
OQ (Operational Qualification)
The documented verification that a system operates in accordance with its approved specifications under all anticipated operating conditions. For LoRaWAN systems, OQ covers functional testing of alarm thresholds, alarm escalation, silence alarm detection, user access controls, audit trail generation, data retention, and RF coverage performance. OQ follows IQ and precedes PQ. See also: IQ, PQ, Validation.
OTAA (Over-The-Air Activation)
The recommended LoRaWAN device activation method, in which a device initiates a join procedure with the join server by transmitting a Join Request containing the DevEUI and AppEUI. The join server responds with a Join Accept containing the DevAddr and parameters used to derive session keys. OTAA provides forward secrecy (new session keys for each join) and a verifiable join event audit trail. See also: ABP, DevEUI, AppKey.
P
PDR (Packet Delivery Rate)
The percentage of expected uplink transmissions from a sensor that are successfully received and processed by the application platform during a defined measurement period. PDR is the primary RF performance KPI for LoRaWAN monitoring systems. Acceptance thresholds are zone-dependent: ≥ 98% per month for Critical Zones; ≥ 95% per month for Standard Zones. A PDR below threshold triggers a deviation investigation. See also: KPI, Critical Zone, Standard Zone.
PIC/S (Pharmaceutical Inspection Co-operation Scheme)
An international co-operation between pharmaceutical regulatory authorities that harmonizes GMP inspection standards. PIC/S guidance documents, including PI 041 (Data Integrity), are influential references for pharmaceutical data integrity requirements applicable to LoRaWAN systems.
PQ (Performance Qualification)
The documented verification that a system performs consistently and reliably within its normal operating environment over time, meeting predefined acceptance criteria. For LoRaWAN monitoring systems, PQ typically includes temperature mapping studies, extended PDR monitoring, calibration verification, and long-term alarm response compliance. PQ follows OQ. See also: IQ, OQ, Validation.
R
Relay (LoRaWAN Relay)
A LoRaWAN feature (defined in TS011) that allows a LoRaWAN device to act as a relay node, extending network coverage by forwarding uplinks from devices that cannot reach a gateway directly. Relays are particularly useful in pharmaceutical facilities with dense building structures that attenuate RF signals. See also: Gateway.
Risk Assessment
A systematic process of evaluating identified risks using risk analysis tools (such as FMEA) to determine their significance and prioritize risk control measures. In LoRaWAN validation, the System Risk Assessment document is the governance artifact that defines the validation scope, component classifications, failure mode mitigations, and residual risk acceptability. See also: FMEA, ICH Q9, GAMP 5.
RSSI (Received Signal Strength Indicator)
A measurement of the power level of a received radio signal, expressed in dBm. RSSI is an indicator of signal coverage: more negative values (e.g., −110 dBm) indicate weaker signals. Used during RF site surveys and PQ temperature mapping to document signal quality at each sensor location. See also: SNR.
S
SF (Spreading Factor)
A LoRa modulation parameter (SF7 through SF12) controlling the trade-off between range and data rate. Higher spreading factors (SF12) provide greater range and noise immunity but reduce data rate and increase time on air. Sensors in areas with poor RF coverage may be assigned higher spreading factors by ADR. See also: ADR, Bandwidth.
Silence Alarm
An application platform alarm triggered when a sensor has not transmitted an uplink for longer than its expected reporting interval plus a configured tolerance margin. The silence alarm is the primary mechanism for detecting sensor failures, battery depletion, or RF coverage gaps in LoRaWAN monitoring systems. Silence alarms in Critical Zones require faster response times than those in Standard Zones. See also: PDR, Critical Zone.
SLA (Service Level Agreement)
A contractual commitment between a service provider (e.g., network server operator, application platform provider) and a customer, defining minimum performance levels. In GxP LoRaWAN deployments, SLAs for network server and application platform availability (typically ≥ 99.5% uptime) must be documented and evaluated as part of supplier qualification. See also: KPI.
SMQR (Supplier and Manufacturer Quality Requirements)
A qualification document (sometimes called a Supplier Qualification Report or Vendor Assessment) used to evaluate and document the quality management capabilities of a supplier or manufacturer. In LoRaWAN validation, SMQR documents are prepared for sensor manufacturers, gateway suppliers, network server providers, and application platform vendors. See also: IQ.
SNR (Signal-to-Noise Ratio)
The ratio of the received signal power to the background noise power, expressed in dB. SNR is a more meaningful indicator of link quality than RSSI alone, as it accounts for the noise floor at the gateway. LoRaWAN can decode signals with negative SNR (down to approximately −20 dB at SF12), enabling communication even with very weak signals. See also: RSSI, SF.
SOP (Standard Operating Procedure)
A documented procedure establishing the accepted method for performing an operation in a pharmaceutical GxP environment. LoRaWAN systems require SOPs for alarm response, calibration, change control, periodic review, deviation management, and system backup.
Standard Zone
A monitored physical area in which a monitoring failure creates an operational concern — a potential quality event requiring investigation — but does not directly and immediately affect a Critical Quality Attribute or product release. Standard zones are GxP-relevant but the chain of causality between a monitoring failure and product impact is less direct, or the time window for response is longer. Typical standard zones include raw material storage, secondary quarantine areas, and laboratory environments. See also: Critical Zone, CQA, PDR.
U
Uplink
A LoRaWAN message transmitted from a device to the network infrastructure (device → gateway → network server → application server). Environmental sensor measurements are transmitted as uplinks at configured intervals. See also: Downlink, PDR.
URS (User Requirements Specification)
A document that defines the operational and functional requirements of a system from the user's perspective, independent of the technical solution. The URS is the primary input to the validation lifecycle and the basis for acceptance criteria in OQ and PQ. In LoRaWAN validation, the URS defines alarm thresholds, reporting intervals, data retention requirements, user roles, and integration requirements.
V
Validation
The documented process of establishing, by objective evidence, that a system consistently performs its intended functions in a manner that meets predetermined specifications and quality attributes. In pharmaceutical GxP environments, validation of computerized systems follows the lifecycle approach defined in GAMP 5: URS → Risk Assessment → IQ → OQ → PQ → Ongoing monitoring. See also: IQ, OQ, PQ, GAMP 5.
W
WFI (Water for Injection)
Highly purified water meeting pharmacopoeial specifications (USP, EP, JP) for use in the manufacture of injectable pharmaceutical products. WFI distribution loops require temperature monitoring (typically 70–80°C for hot circulation loops) to prevent microbial contamination. WFI loop temperature monitoring is a Critical Zone application for LoRaWAN. See also: Critical Zone.
WHO (World Health Organization)* (also OMS — Organisation Mondiale de la Santé)*
The United Nations specialized agency for international public health. WHO publishes technical guidance relevant to pharmaceutical GxP environments, including WHO Technical Report Series (TRS) documents covering GMP, GDP, temperature-controlled storage, cold chain management, and data integrity. WHO guidelines are recognized in many countries — particularly in emerging markets — as authoritative regulatory references, and are mandatory for pharmaceutical products procured through UNICEF and other UN procurement channels. See also: GDP, GMP, GxP.